Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

BAG-6 is essential for selective elimination of defective proteasomal substrates.

Minami R, Hayakawa A, Kagawa H, Yanagi Y, Yokosawa H, Kawahara H.

J Cell Biol. 2010 Aug 23;190(4):637-50. doi: 10.1083/jcb.200908092. Epub 2010 Aug 16.

2.

BAG6/BAT3: emerging roles in quality control for nascent polypeptides.

Kawahara H, Minami R, Yokota N.

J Biochem. 2013 Feb;153(2):147-60. doi: 10.1093/jb/mvs149. Epub 2012 Dec 28. Review.

PMID:
23275523
3.

Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions.

Loureiro J, Ploegh HL.

Adv Immunol. 2006;92:225-305. Review.

PMID:
17145306
4.

The regulation of proteasome degradation by multi-ubiquitin chain binding proteins.

Miller J, Gordon C.

FEBS Lett. 2005 Jun 13;579(15):3224-30. Epub 2005 Mar 31. Review.

5.

Therapeutically targeting the SUMOylation, Ubiquitination and Proteasome pathways as a novel anticancer strategy.

Driscoll JJ, Dechowdhury R.

Target Oncol. 2010 Dec;5(4):281-9. doi: 10.1007/s11523-010-0165-2. Epub 2010 Nov 27. Review.

PMID:
21125340
6.

Chaperone activities of the 26S and 20S proteasome.

Yano M, Kanesaki Y, Koumoto Y, Inoue M, Kido H.

Curr Protein Pept Sci. 2005 Apr;6(2):197-203. Review.

PMID:
15853655
7.

The proteasome activator 11 S REG (PA28) and class I antigen presentation.

Rechsteiner M, Realini C, Ustrell V.

Biochem J. 2000 Jan 1;345 Pt 1:1-15. Review.

Supplemental Content

Support Center